ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 242

Elevated Systemic Blood Pressure Is Associated With Increased Prevalent Knee Osteoarthritis and Knee Pain: Data From The Osteoarthritis Initiative

Grace H. Lo1, Timothy E. McAlindon2, Jeffrey N. Katz3, Jeffrey B. Driban4, Lori Lyn Price5,6, Charles Eaton7, Nancy Petersen8, Christie Ballantyne9 and Maria E. Suarez-Almazor10, 1VA HSR&D Center for Innovations in Quality, Effectiveness and Safety; Medical Care Line and Research Care Line; Department of Medicine, Michael E. DeBakey VA Medical Center, Baylor College of Medicine, Houston, TX, 2Division of Rheumatology, Tufts Medical Center, Boston, MA, 3Rheumatology and Orthopedics, Brigham and Women's Hospital, Boston, MA, 4Rheumatology, Tufts Medical Center, Boston, MA, 5Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, MA, 6Biostatistics Research Center, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, MA, 7Center for Primary Care and Prevention, Memorial Hospital of Rhode Island, Providence, RI, 8Michael E. DeBakey VA Medical Center Health Services Research and Development Center of Excellence, Houston, TX, 9Department of Medicine, Baylor College of Medicine, Houston, TX, 10The Department of General Internal Medicine, The University of Texas, MD Anderson Cancer Center, Houston, TX

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: Hypertension and osteoarthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Osteoarthritis - Clinical Aspects I: Risk Factors for and Sequelae of Osteoarthritis.

Session Type: Abstract Submissions (ACR)

Background/Purpose: Epidemiologic studies have linked osteoarthritis (OA) to atheromatous vascular disease, both age-related diseases.  Systemic hypertension (HTN) is an important risk factor for cardiovascular disease and may also be for OA.  The objective of this study was to evaluate whether there is an association between HTN and prevalent knee OA and pain in the Osteoarthritis Initiative (OAI).

Methods: This is a longitudinal study of the OAI, a multi-center observational study of knee OA. Systolic (SBP) and extensive medication data were accumulated on participants at their OAI baseline,  12-, 24-, and 36- month visits.  Bilateral PA knee radiographs were taken at the OAI 48- month visit.  Central readers assessed radiographic OA severity, Kellgren and Lawrence (KL) grade (0-4).  WOMAC pain scores were assessed for both knees at the 48- month visit.  The greatest WOMAC score within one participant represented the maximal WOMAC score.  There may be a lag between exposure to HTN and development of OA; therefore, we evaluated a 4 year interval between exposure and outcome. We performed logistic regression of quartiles of baseline SBP and 48- month status of prevalent radiographic OA (KL > 2) in either knee.  We evaluated prevalent instead of incident knee OA to minimize the likelihood of right sided censorship.  We performed a least square means of the maximum WOMAC score by quartile of SBP.  The adjusted model included age, sex, and body mass index (BMI) as covariates.  To eliminate the influence of HTN treatments, we performed subgroup analyses of those not taking anti-HTN medications at the baseline visit.  To address the possibility that participants’ SBPs fluctuated over time, we performed a sensitivity analysis using mean SBP over the baseline, 12-, 24-, and 36- month OAI visits as the exposure.

Results: 3644 people were included with a mean age of 61.1 (9.1), mean BMI of 28.5 (2.7), 42% were male.  61% of participants were not on anti-HTN medications.  20%, 13%, 5%, and 1% were on 1, 2, 3, and > 4 anti-HTN medications.

 

Outcome = Prevalent Knee OA

Outcome = Knee Pain

N = 3644

Prevalence of Knee OA by SBP Quartile

Unadjusted Odds Ratio (95% CI)

Odds Ratio (95% CI) Adjusted for Age, Sex, BMI

LS Means of Maximal WOMAC Score, Adjusted for Age, Sex, BMI, Rad OA status

SBP Quartile 1(76 – 112)

531/1031 (52%)

Referent

Referent

2.6 (2.4 – 2.8)

SBP Quartile 2 (114 – 122)

519/846 (61%)

1.5 (1.2 – 1.8)

1.2 (1.0 – 1.5)

2.8 (2.6 – 3.0)

SBP Quartile 3 (123 – 134)

586/865 (68%)

2.0 (1.6 – 2.4)

1.4 (1.2 – 1.7)

2.9 (2.7 – 3.1)

SBP Quartile 4 (135 – 210)

619/902 (69%)

2.1 (1.7 – 2.5)

1.3 (1.0 – 1.6)

3.2 (3.0 – 3.4)

 

 

p-for trend       < 0.0001

p-for trend           = 0.006

p trend                = 0.0016

Table. Systolic blood pressure is associated with prevalent radiographic knee osteoarthritis and knee pain.  Logistic regression of SBP quartile and prevalent knee OA.  Least Squared Means of maximal WOMAC score by SBP quartiles, adjusted for age, sex, BMI, and radiographic OA status.

Sensitivity analyses of participants who did not report anti-HTN medications showed similar results, as did using mean SBP over baseline – OAI 36 month as the exposure.

Conclusion: To our knowledge, this is the first epidemiologic study to show elevated systemic blood pressure is associated with increased prevalence of knee OA and greater levels of knee pain. The associations were weakened when adjusting for age, sex, and BMI, but were still significant.  These findings suggest a new and promising avenue for research on disease modification as well as symptom control in knee OA.  Future epidemiologic studies are needed to confirm these findings.


Disclosure:

G. H. Lo,
None;

T. E. McAlindon,
None;

J. N. Katz,
None;

J. B. Driban,
None;

L. L. Price,
None;

C. Eaton,
None;

N. Petersen,
None;

C. Ballantyne,
None;

M. E. Suarez-Almazor,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/elevated-systemic-blood-pressure-is-associated-with-increased-prevalent-knee-osteoarthritis-and-knee-pain-data-from-the-osteoarthritis-initiative/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology